A caregiver-person with schizophrenia partnership to improve oral health education
Affiliation auteurs | !!!! Error affiliation !!!! |
Titre | A caregiver-person with schizophrenia partnership to improve oral health education |
Type de publication | Journal Article |
Year of Publication | 2019 |
Auteurs | Rat C, Peteuil A, Reynaud M, Millot I, Carpentier M, Soudry-Faure A, Denis F |
Journal | SANTE PUBLIQUE |
Volume | 31 |
Pagination | 405-415 |
Date Published | MAY-JUN |
Type of Article | Article |
ISSN | 0995-3914 |
Mots-clés | Global health, interventional research, Oral Health, Patient partnership, Schizophrenia, Therapeutic education |
Résumé | Introduction: Poor oral health in persons with schizophrenia is a major public health issue affecting 600,000 people in France. The aim of this article was to present the different stages in the development of a specific oral health educational program for persons with schizophrenia. It takes into account experimental knowledge of these persons and presents the results of the feasibility study. Patients and Method: The focus group method was applied to a group of health professionals and users to highlight an exploratory corpus in order to develop an oral health educational program. An expert group including persons with schizophrenia among others validated the fields and tools of this program. A feasibility study was then conducted in a control group of 7 persons with schizophrenia. Results: Altogether, 26 persons participated in this feasibility study. The main fields investigated by the expert group aimed to promote personal responsibility for one's health, to improve access to the healthcare system and to promote the global management of health. The feasibility study showed the ability of this program to change persons with schizophrenia representations and knowledge of this health problem. Most educational tools were considered relevant. Conclusion: An oral health educational program was built as part of a caregiver-persons with schizophrenia partnership and showed its feasibility. A multicentric randomized trial is currently ongoing to assess the efficacy of this program with a high level of proof. |
DOI | 10.3917/spub.193.0405 |